These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of pulsatile plasma concentrations of growth hormone in healthy dogs and dogs with dilated cardiomyopathy. Beijerink NJ; Lee WM; Stokhof AA; Voorhout G; Mol JA; Kooistra HS Am J Vet Res; 2011 Jan; 72(1):59-63. PubMed ID: 21194336 [TBL] [Abstract][Full Text] [Related]
6. Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy. Giustina A; Lorusso R; Borghetti V; Bugari G; Misitano V; Alfieri O Am Heart J; 1996 Mar; 131(3):620-2. PubMed ID: 8604653 [No Abstract] [Full Text] [Related]
7. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. Fazio S; Sabatini D; Capaldo B; Vigorito C; Giordano A; Guida R; Pardo F; Biondi B; Saccà L N Engl J Med; 1996 Mar; 334(13):809-14. PubMed ID: 8596546 [TBL] [Abstract][Full Text] [Related]
8. Myocardial performance and efficiency as assessed by energetic parameters derived from pressure-volume relations and wall thickness in human ventricles. Holubarsch C; Hasenfuss G; Körner M; von Herrath M; Bonzel T; Tarnowska R; Just H Z Kardiol; 1986; 75 Suppl 2():100-4. PubMed ID: 3727668 [No Abstract] [Full Text] [Related]
9. [Growth hormone and dilated cardiomyopathy]. Dreifuss P Dtsch Med Wochenschr; 2002 Jun; 127(23):1261-3. PubMed ID: 12053286 [No Abstract] [Full Text] [Related]
10. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742 [TBL] [Abstract][Full Text] [Related]
11. [Possibilities of the use of angiocardioscintigraphy in non-ischemic heart diseases]. Biggi A; Farinelli MC; D'Angeli B; Camuzzini GF G Ital Cardiol; 1988 Jun; 18(6):532-8. PubMed ID: 3215427 [No Abstract] [Full Text] [Related]
12. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Benso A; Broglio F; Gottero C; Di Vito L; Arvat E; Bobbio M; Ghigo E J Endocrinol Invest; 1999; 22(10 Suppl):63. PubMed ID: 10727049 [No Abstract] [Full Text] [Related]
13. Congestive heart failure and the growth hormone/insulin-like growth factor-1 (GH/IGF-1) system. Dreifuss P Am J Cardiol; 2003 Jul; 92(2):245-6. PubMed ID: 12860243 [No Abstract] [Full Text] [Related]
14. The growth hormone IGF-I axis in dilated cardiomyopathy. Jenkins RC; Ross RJ Clin Endocrinol (Oxf); 1999 Apr; 50(4):415-6. PubMed ID: 10468899 [No Abstract] [Full Text] [Related]
15. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis]. Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634 [TBL] [Abstract][Full Text] [Related]
17. [Myocardial dynamics and contractility of the left ventricle in aortic valve insufficiency of various degrees. Studies on 16 patients and comparison with 4 patients without aortic valve insufficiency or hypertension]. Degenring FH Arch Kreislaufforsch; 1971; 64(3):215-24. PubMed ID: 5088418 [No Abstract] [Full Text] [Related]
18. Pituitary and peripheral insulin-like growth factor-I regulation by thyroid hormone. Cacicedo L; de los Frailes MT; Lorenzo MJ; Sanchez Franco F Ann N Y Acad Sci; 1993 Aug; 692():287-90. PubMed ID: 8215034 [No Abstract] [Full Text] [Related]
19. Right ventricular systolic pressure gradients in aortic valve disease. Epstein EJ; Doukas NG; Coulshed N; Brown AK Br Heart J; 1967 Jul; 29(4):490-504. PubMed ID: 4226389 [No Abstract] [Full Text] [Related]